Cargando…
Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi
Diseases caused by fungi can occur in healthy people, but immunocompromised patients are the major risk group for invasive fungal infections. Cases of fungal resistance and the difficulty of treatment make fungal infections a public health problem. This review explores mechanisms used by fungi to pr...
Autores principales: | Parente-Rocha, Juliana Alves, Bailão, Alexandre Melo, Amaral, André Correa, Taborda, Carlos Pelleschi, Paccez, Juliano Domiraci, Borges, Clayton Luiz, Pereira, Maristela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485324/ https://www.ncbi.nlm.nih.gov/pubmed/28694566 http://dx.doi.org/10.1155/2017/9870679 |
Ejemplares similares
-
Terpinen-4-ol, tyrosol, and β-lapachone as potential antifungals against dimorphic fungi
por: Brilhante, Raimunda Sâmia Nogueira, et al.
Publicado: (2016) -
Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier
por: Taborda, Carlos P., et al.
Publicado: (2017) -
Immunoproteomic Approach of Extracellular Antigens From Paracoccidioides Species Reveals Exclusive B-Cell Epitopes
por: Moreira, André Luís Elias, et al.
Publicado: (2020) -
In Vitro Antifungal Activity of LL-37 Analogue Peptides against Candida spp.
por: Pinilla, Gladys, et al.
Publicado: (2022) -
Chemoproteomic identification of molecular targets of antifungal prototypes, thiosemicarbazide and a camphene derivative of thiosemicarbazide, in Paracoccidioides brasiliensis
por: Borba, Joyce Villa Verde Bastos, et al.
Publicado: (2018)